Application of Single and Cooperative Different Delivery Systems for the Treatment of Intervertebral Disc Degeneration

Overview

Journal Front Bioeng Biotechnol

Date 2022 Dec 1

PMID 36452213

Authors

Zongtai Liu

Changfeng Fu

Affiliations

Soon will be listed here.

Abstract

Intervertebral disc (IVD) degeneration (IDD) is the most universal pathogenesis of low back pain (LBP), a prevalent and costly medical problem across the world. Persistent low back pain can seriously affect a patient's quality of life and even lead to disability. Furthermore, the corresponding medical expenses create a serious economic burden to both individuals and society. Intervertebral disc degeneration is commonly thought to be related to age, injury, obesity, genetic susceptibility, and other risk factors. Nonetheless, its specific pathological process has not been completely elucidated; the current mainstream view considers that this condition arises from the interaction of multiple mechanisms. With the development of medical concepts and technology, clinicians and scientists tend to intervene in the early or middle stages of intervertebral disc degeneration to avoid further aggravation. However, with the aid of modern delivery systems, it is now possible to intervene in the process of intervertebral disc at the cellular and molecular levels. This review aims to provide an overview of the main mechanisms associated with intervertebral disc degeneration and the delivery systems that can help us to improve the efficacy of intervertebral disc degeneration treatment.

Citing Articles

Immune-defensive microspheres promote regeneration of the nucleus pulposus by targeted entrapment of the inflammatory cascade during intervertebral disc degeneration.

Zhou L, Cai F, Zhu H, Xu Y, Tang J, Wang W Bioact Mater. 2024; 37:132-152.

PMID: 38549774 PMC: 10972768. DOI: 10.1016/j.bioactmat.2024.03.020.

Exosomal U2AF2 derived from human bone marrow mesenchymal stem cells attenuates the intervertebral disc degeneration through circ_0036763/miR-583/ACAN axis.

Chen X, Cai D, Li H, Wei Q, Li X, Han Z Regen Ther. 2024; 25:344-354.

PMID: 38362337 PMC: 10867602. DOI: 10.1016/j.reth.2024.01.006.

Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.

Luo Y, Sun M, Tan L, Li T, Min L Pharmaceutics. 2023; 15(12).

PMID: 38140058 PMC: 10747574. DOI: 10.3390/pharmaceutics15122717.

References

Zhang Q, Huang M, Wang X, Xu X, Ni M, Wang Y . Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. J Orthop Res. 2012; 30(8):1238-43. DOI: 10.1002/jor.22069. View

Xu P, Guan J, Chen Y, Xiao H, Yang T, Sun H . Stiffness of photocrosslinkable gelatin hydrogel influences nucleus pulposus cell propertiesin vitro. J Cell Mol Med. 2020; 25(2):880-891. PMC: 7812302. DOI: 10.1111/jcmm.16141. View

Pockert A, Richardson S, Le Maitre C, Lyon M, Deakin J, Buttle D . Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum. 2009; 60(2):482-91. DOI: 10.1002/art.24291. View

Huang C, Gu W . Effects of mechanical compression on metabolism and distribution of oxygen and lactate in intervertebral disc. J Biomech. 2008; 41(6):1184-96. PMC: 2398770. DOI: 10.1016/j.jbiomech.2008.02.002. View

Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

Hoffman A . Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 54(1):3-12. DOI: 10.1016/s0169-409x(01)00239-3. View

Elfervig M, Minchew J, Francke E, Tsuzaki M, Banes A . IL-1beta sensitizes intervertebral disc annulus cells to fluid-induced shear stress. J Cell Biochem. 2001; 82(2):290-8. DOI: 10.1002/jcb.1153. View

Kurian A, Singh R, Patel K, Lee J, Kim H . Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics. Bioact Mater. 2021; 8:267-295. PMC: 8424393. DOI: 10.1016/j.bioactmat.2021.06.027. View

Adams M, Roughley P . What is intervertebral disc degeneration, and what causes it?. Spine (Phila Pa 1976). 2006; 31(18):2151-61. DOI: 10.1097/01.brs.0000231761.73859.2c. View

10.

Kepler C, Markova D, Dibra F, Yadla S, Vaccaro A, Risbud M . Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1β in painful human intervertebral discs. Spine (Phila Pa 1976). 2013; 38(11):873-80. DOI: 10.1097/BRS.0b013e318285ae08. View

11.

McCarthy D, Clark R, Bartling T, Trebak M, Melendez J . Redox control of the senescence regulator interleukin-1α and the secretory phenotype. J Biol Chem. 2013; 288(45):32149-32159. PMC: 3820855. DOI: 10.1074/jbc.M113.493841. View

12.

Tang G, Han X, Lin Z, Qian H, Chen B, Zhou C . Accelerates Intervertebral Disc Degeneration by Inducing Pyroptosis of Nucleus Pulposus Cells via the ROS-NLRP3 Pathway. Oxid Med Cell Longev. 2021; 2021:4657014. PMC: 7870295. DOI: 10.1155/2021/4657014. View

13.

Wang J, Markova D, Anderson D, Zheng Z, Shapiro I, Risbud M . TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem. 2011; 286(46):39738-49. PMC: 3220535. DOI: 10.1074/jbc.M111.264549. View

14.

Paul C, Zuiderbaan H, Doulabi B, van der Veen A, van de Ven P, Smit T . Simulated-physiological loading conditions preserve biological and mechanical properties of caprine lumbar intervertebral discs in ex vivo culture. PLoS One. 2012; 7(3):e33147. PMC: 3302815. DOI: 10.1371/journal.pone.0033147. View

15.

Lee J, Song J, Baek M, Jung H, Kang H, Han I . Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res. 2010; 29(2):265-9. DOI: 10.1002/jor.21210. View

16.

Xu H, Mei Q, He J, Liu G, Zhao J, Xu B . Correlation of matrix metalloproteinases-1 and tissue inhibitor of metalloproteinases-1 with patient age and grade of lumbar disk herniation. Cell Biochem Biophys. 2014; 69(3):439-44. DOI: 10.1007/s12013-014-9815-9. View

17.

Gabr M, Jing L, Helbling A, Sinclair S, Allen K, Shamji M . Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res. 2010; 29(1):1-7. PMC: 3007672. DOI: 10.1002/jor.21206. View

18.

Jang H, Shin J, Oh S, Byun J, Lee J . PCL/HA Hybrid Microspheres for Effective Osteogenic Differentiation and Bone Regeneration. ACS Biomater Sci Eng. 2021; 6(9):5172-5180. DOI: 10.1021/acsbiomaterials.0c00550. View

19.

Schmitt C, Radetzki F, Stirnweiss A, Mendel T, Ludtka C, Friedmann A . Long-term pre-clinical evaluation of an injectable chitosan nanocellulose hydrogel with encapsulated adipose-derived stem cells in an ovine model for IVD regeneration. J Tissue Eng Regen Med. 2021; 15(7):660-673. DOI: 10.1002/term.3216. View

20.

Alinejad Y, Adoungotchodo A, Grant M, Epure L, Antoniou J, Mwale F . Injectable Chitosan Hydrogels with Enhanced Mechanical Properties for Nucleus Pulposus Regeneration. Tissue Eng Part A. 2018; 25(5-6):303-313. DOI: 10.1089/ten.TEA.2018.0170. View